These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9470932)

  • 21. PROGNOSIS IN RAYNAUD'S PHENOMENON AFTER SYMPATHECTOMY.
    JOHNSTON EN; SUMMERLY R; BIRNSTINGL M
    Br Med J; 1965 Apr; 1(5440):962-4. PubMed ID: 14260626
    [No Abstract]   [Full Text] [Related]  

  • 22. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
    Meyrick Thomas RH; Rademaker M; Grimes SM; MacKay A; Kovacs IB; Cook ED; Bowcock SM; Kirby JD
    Br J Dermatol; 1987 Aug; 117(2):237-41. PubMed ID: 3307894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superselective digital sympathectomy in Raynaud's phenomenon.
    Egloff DV; Mifsud RP; Verdan C
    Hand; 1983 Feb; 15(1):110-4. PubMed ID: 6852651
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral sympathectomy for Raynaud's phenomenon: a salvage procedure.
    Wang WH; Lai CS; Chang KP; Lee SS; Yang CC; Lin SD; Liu CM
    Kaohsiung J Med Sci; 2006 Oct; 22(10):491-9. PubMed ID: 17098681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reoperative digital sympathectomy in refractory Raynaud's phenomenon.
    Dorafshar AH; Seitz IA; Zachary L
    Plast Reconstr Surg; 2009 Jan; 123(1):36e-38e. PubMed ID: 19116527
    [No Abstract]   [Full Text] [Related]  

  • 31. Digital sympathectomy for refractory Raynaud's phenomenon in an adolescent.
    Drake DB; Kesler RW; Morgan RF
    J Rheumatol; 1992 Aug; 19(8):1286-8. PubMed ID: 1383543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis.
    Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF
    Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Considerations on the remote results of thoracic ganglionectomy in Raynaud's disease and Raynaud's syndrome of the upper extremities].
    MONTORSI W; GHIRINGHELLI C; MASCETTI M; GALLO G
    Minerva Cardioangiol; 1960 Jun; 8():266-76. PubMed ID: 14423772
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.
    Selenko-Gebauer N; Duschek N; Minimair G; Stingl G; Karlhofer F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii45-8. PubMed ID: 16987835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microsurgical revascularisation of the hand in scleroderma.
    Jones NF; Raynor SC; Medsger TA
    Br J Plast Surg; 1987 May; 40(3):264-9. PubMed ID: 3594054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervicothoracic sympathectomy for Raynaud's syndrome.
    Lowell RC; Gloviczki P; Cherry KJ; Bower TC; Hallett JW; Schirger A; Pairolero PC
    Int Angiol; 1993 Jun; 12(2):168-72. PubMed ID: 8370999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interdigital periarterial sympathectomy: treatment of severe and refractory Raynaud's phenomenon].
    Longy-Boursier M; Boisseau C; Bovet JL; Germain P; Fach J; Bloch-Michel C
    Presse Med; 1998 Nov; 27(35):1791. PubMed ID: 9850696
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.